News: Sanofi SA (SNY)

SNY on New York Consolidated

51.63USD
11 Jul 2014
Price Change (% chg)

$-0.04 (-0.08%)
Prev Close
$51.67
Open
$51.45
Day's High
$51.95
Day's Low
$51.34
Volume
806,378
Avg. Vol
971,313
52-wk High
$54.64
52-wk Low
$46.95

Search Stocks
Select another date:

Fri, Jul 11 2014

Photo

Sanofi dengue vaccine promising but questions remain

PARIS - The first vaccine against dengue fever, from France's Sanofi, provided moderate protection in a large clinical study, but questions remain as to how well it can help fight the world's fastest-growing tropical disease. | Video

RPT-Sanofi dengue vaccine promising but questions remain

(Repeats with no change to text to reach more subscribers)

Sanofi dengue vaccine promising but questions remain

PARIS - The first vaccine against dengue fever, from France's Sanofi, provided moderate protection in a large clinical study, but questions remain as to how well it can help fight the world's fastest-growing tropical disease.

Sanofi dengue vaccine promising but questions remain

* Currently no vaccine for expanding mosquito-borne disease

Regeneron drug tames eczema in study

PARIS/NEW YORK - An experimental drug from Sanofi and Regeneron Pharmaceuticals Inc significantly reduced skin lesions and itching in adult patients with atopic dermatitis, a chronic form of eczema that is poorly controlled by standard drugs, the companies said on Wednesday.

Sanofi-Regeneron drug tames eczema in study

PARIS/NEW YORK, July 9 - An experimental drug from Sanofi and Regeneron Pharmaceuticals Inc significantly reduced skin lesions and itching in adult patients with atopic dermatitis, a chronic form of eczema that is poorly controlled by standard drugs, the companies said on Wednesday.

Sanofi sues Eli Lilly over insulin rival to Lantus

- Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.

Sanofi sues Eli Lilly over insulin rival to Lantus

July 8 - Sanofi SA, whose top-selling Lantus helps diabetics control blood sugar levels, has filed a lawsuit accusing Eli Lilly and Co of infringing seven patents related to insulin and devices used to deliver it.

European shares retreat after weak German data

LONDON, July 7 - European stock markets retreated on Monday after weak German economic data took the wind out of a rally that had pushed a leading regional index back towards 6-1/2 year highs.

European shares retreat after weak German data

* FTSEurofirst 300 down 0.6 pct, still near 6-1/2 year high

Select another date:
Search Stocks